ENDONOVO THERAPEUTICS, INC. Interest Payable, Current
ENDONOVO THERAPEUTICS, INC. (ENDV) had Interest Payable, Current of $3.54 million as of 2022-12-31, per its 10-K filed 2023-04-17.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2023-04-17
- 2022-12-31: Interest Payable, Current $3.54M.
- 2022-09-30: Interest Payable, Current $3.28M.
- 2022-06-30: Interest Payable, Current $3.03M.
- 2022-03-31: Interest Payable, Current $2.76M.
| Period end | Interest Payable, Current |
|---|---|
| 2022-12-31 | $3.54M 10-K · filed 2023-04-17 |
| 2022-09-30 | $3.28M 10-Q · filed 2022-11-21 |
| 2022-06-30 | $3.03M 10-Q · filed 2022-08-22 |
| 2022-03-31 | $2.76M 10-Q · filed 2022-05-19 |
| 2021-12-31 | $2.53M 10-K · filed 2023-04-17 |
| 2021-09-30 | $2.33M 10-Q · filed 2021-11-19 |
| 2021-06-30 | $2.16M 10-Q · filed 2021-08-23 |
| 2021-03-31 | $2.11M 10-Q · filed 2021-05-24 |
| 2020-12-31 | $1.90M 10-K · filed 2022-04-14 |
| 2020-09-30 | $1.87M 10-Q · filed 2020-11-19 |
| 2020-06-30 | $1.62M 10-Q · filed 2020-08-19 |
| 2020-03-31 | $1.49M 10-Q · filed 2020-06-12 |
| 2019-12-31 | $1.32M 10-K · filed 2021-04-13 |
| 2019-09-30 | $1.13M 10-Q · filed 2019-11-19 |
| 2018-12-31 | $786.10K 10-K · filed 2020-05-04 |